comparemela.com

Latest Breaking News On - Overstitch sx endoscopic suturing systems - Page 1 : comparemela.com

Social Capital Suvretta Holdings Corp I (NASDAQ:DNAA) and Apollo Endosurgery (NASDAQ:APEN) Critical Comparison

Social Capital Suvretta Holdings Corp. I (NASDAQ:DNAA – Get Rating) and Apollo Endosurgery (NASDAQ:APEN – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations. Analyst Ratings This is a […]

Apollo Endosurgery (NASDAQ:APEN) Releases Quarterly Earnings Results, Misses Expectations By $0 01 EPS

Apollo Endosurgery (NASDAQ:APEN – Get Rating) announced its quarterly earnings data on Tuesday. The biotechnology company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.01), MarketWatch Earnings reports. Apollo Endosurgery had a negative return on equity of 148.35% and a negative net margin of 39.19%. During the same […]

Apollo Endosurgery (NASDAQ:APEN) Upgraded to Hold by Zacks Investment Research

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Analysts Anticipate Apollo Endosurgery, Inc (NASDAQ:APEN) to Post -$0 21 EPS

Wall Street brokerages forecast that Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) will post ($0.21) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Apollo Endosurgery’s earnings. The lowest EPS estimate is ($0.27) and the highest is ($0.16). Apollo Endosurgery reported earnings per share of […]

Apollo Endosurgery, Inc (NASDAQ:APEN) Expected to Announce Quarterly Sales of $15 69 Million

Equities analysts predict that Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) will report $15.69 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Apollo Endosurgery’s earnings, with the highest sales estimate coming in at $15.90 million and the lowest estimate coming in at $15.49 million. Apollo […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.